<DOC>
	<DOCNO>NCT00092963</DOCNO>
	<brief_summary>The purpose study test effectiveness approve drug early treatment migraine pain still mild .</brief_summary>
	<brief_title>Study Test Approved Product Early Treatment Migraine ( 0462-065 )</brief_title>
	<detailed_description />
	<mesh_term>Migraine Disorders</mesh_term>
	<mesh_term>Rizatriptan</mesh_term>
	<criteria>6month history migraine Migraine attack typically mild begin 14 migraine attack per month Heart disease High blood pressure</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
</DOC>